References

• Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E. (For the ESMO Guidelines Working Group) (2010) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol (2012) 23 (suppl_7): vii11-vii19. https://academic.oup.com/annonc/article/23/suppl_7/vii11/144433/Locally-recurrent-or-metastatic-breast-cancer-ESMO
• Coghlin C, Murray GI. (2010) Current and emerging concepts in tumour metastasis. J Pathol. (Spet. 2010) 222(1):1-15. https://www.ncbi.nlm.nih.gov/pubmed/20681009
• Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, Lewis VO, Ma J. (et al). (2009). Imaging bone metastases in breast cancer: Techniques and recommendations for diagnosis. The Lancet Oncology 10 (6): 606–614 https://www.ncbi.nlm.nih.gov/pubmed/19482249
• Disibio G, French SW. (2008) Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med. (Jun 2008) 132(6):931-9. https://www.ncbi.nlm.nih.gov/pubmed/18517275
• Elston CW, Ellis IO. (1991) Pathologic prognostic factors in breast cancer. I. The value of histological grades in breast cancer. Experience from a large study with long-term follow-up. Histopathology (1991), 19:403-410. https://www.ncbi.nlm.nih.gov/pubmed/1757079
• Kreisman H, Wolkove N, Finkelstein HS, (et al). (1983) Breast cancer and thoracic metastases: review of 119 patients. Thorax. (1983);38:175–179. https://www.ncbi.nlm.nih.gov/pubmed/6857580
• Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ. (et al). (2015) Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? Br J Cancer. 2015 Apr 28;112(9):1445-51. https://www.ncbi.nlm.nih.gov/pubmed/25880008
• Narod SA. (2012) Tumour size predicts long-term survival among women with lymph node-positive breast cancer Curr Oncol. 2012 Oct; 19(5): 249–253. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457875/
• O’Shaughnessy J. (2005) Extending Survival with Chemotherapy in Metastatic Breast Cancer Oncologist. 2005;10 Suppl 3:20-9. http://theoncologist.alphamedpress.org/content/10/suppl_3/20.long
• Parise CA, Caggiano V. (2014) Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers Journal of Cancer Epidemiology 2014(2):469251 · May 2014 https://www.hindawi.com/journals/jce/2014/469251/
• Tan W, Zhang W, Stranser A, Grivennivov S, Chen JQ, Hoffman RM, Karin M. (2011) Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature. 2011 Feb 24;470(7335):548-53. https://www.ncbi.nlm.nih.gov/pubmed/21326202
• Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. (July 2010)70(14):5649-69. https://www.ncbi.nlm.nih.gov/pubmed/20610625
• Vollmer RT. (2009) Primary Lung Cancer vs Metastatic Breast Cancer: A Probabilistic Approach. Am J Clin Pathol (2009) 132:391-395 https://www.ncbi.nlm.nih.gov/pubmed/19687315
• Wu SG, He ZY, Li Q, Sun JY, Li FY, Lin Q, Lin HX, Guan XX.(2013) Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients. PLoS One. 2013 Apr 23;8(4):e61410. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634079/